Various administration forms of nitrates and their possibilities.
This article reviews the development and pharmacokinetics of a number of new dosage formulations (e.g. transdermal patches and buccal tablets) and new active substances (e.g. isosorbide 5-mononitrate) which have recently been introduced to overcome some of the problems inherent in conventional formulations of organic nitrates.
Jonsson
U E
UE
D000279:Administration, Cutaneous; D000336:Aerosols; D003692:Delayed-Action Preparations; D006801:Humans; D007548:Isosorbide Dinitrate / Q000008:administration & dosage / Q000031:analogs & derivatives; D007700:Kinetics; D009566:Nitrates / Q000008:administration & dosage* / Q000627:therapeutic use
D000336:Aerosols; D003692:Delayed-Action Preparations; D009566:Nitrates; D007548:Isosorbide Dinitrate; C030397:isosorbide-5-mononitrate